CY2018020I1
(en )
2019-07-10
TREATMENT OF ROMRE'S DISEASE
NO993051D0
(en )
1999-06-21
Intranasal formulations for the treatment of sexual disorders
DE69925306D1
(en )
2005-06-16
TREATMENT OF HYDROCARBONGAS
ID25792A
(en )
2000-11-02
ANTIBODIES OF HUMAN CD40
ID27841A
(en )
2001-04-26
THERAPEUTIC BIARILS
DE69936335D1
(en )
2007-08-02
USE OF MORPHOLINOL FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS
DK1063990T3
(en )
2007-05-21
Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
PT1077940E
(en )
2004-10-29
4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURIGINAL DERMATOSES
ID27191A
(en )
2001-03-08
METHODS FOR TREATMENT OF INSOMNIA
DE69921571D1
(en )
2004-12-09
MASSAGER
NO20005179D0
(en )
2000-10-13
Drug treatment
NO20020062L
(en )
2002-01-07
Treatment of neurotic disorders
ID27214A
(en )
2001-03-08
TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
IS5951A
(en )
2001-05-22
5HT1 antidepressant for the treatment of depression
NO20012106L
(en )
2001-06-21
Means for the treatment of disorders of bone metabolism
ID28032A
(en )
2001-05-03
TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
ATE230741T1
(en )
2003-01-15
3-TETRAHYDROPYRIDINE-4-YL-INDOLE FOR THE TREATMENT OF PSYCHOTIC DISORDERS
NO20010390D0
(en )
2001-01-23
Treatment of anxiety disorders
NO20012612D0
(en )
2001-05-28
Isonipecotamides for the treatment of integrin-mediated disorders
ID30458A
(en )
2001-12-06
OSANETAN IN TREATMENT OF SOUL DISORDERS
AR026062A1
(en )
2002-12-26
TREATMENT OF EYE DISORDERS
PT1200447E
(en )
2004-02-27
OXAZINOCARBAZOLES FOR THE TREATMENT OF DISEASES OF THE SNC
EE200200670A
(en )
2004-08-16
S-methyldihydroziprasidone for the treatment of psychiatric and ocular disorders
IL126681A0
(en )
1999-08-17
Treatment of trauma-related conditions
NO20006383L
(en )
2000-12-14
Process of treatment